In Vitro and In Vivo Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis

Time:2018-05-13 / View:303 times

Prev: Single- and Multiple-Dose Study to Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I Versus Linezolid in Healthy Adult Subjects

Next: Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects.

Back